© 2010 Genitourinary Publishing, Inc.
WILEX AG Receives Preliminary Results of
Phase 3 Trial With the Diagnostic REDECTANE®
MUNICH—The biopharmaceutical company WILEX AG was informed by the external clinical research organisation (CRO) that the results of the preliminary data of the phase 3 trial with REDECTANE® expected at the end of December have now been completed earlier than anticipated.
Excess Body Weight Linked With More Than 100,000 New Cancer Diagnoses Each Year
in the United States
According to estimates from the American Institute for
Cancer Research (AICR), excess body weight may be responsible for more than 100,000 new cancer diagnoses each year in the United States, including renal cell carcinoma.
Hemoglobin Levels Predict Outcomes
With Bevacizumab
SAN FRANCISCO—Patients with advanced renal cell carcinoma who responded to angiogenesis inhibitor drugs also had higher hemoglobin levels, a researcher reported here. The finding suggested that hemoglobin responses might accurately predict...
.
Click the arrow to read more...
EDITOR'S MEMO - Robert A. Figlin, MD
Optimizing Our Strategies—Removal of the
Primary Tumor and Planning Treatment with
Targeted Therapies
Looking back at our coverage of relevant topics during the last year, advances in medical therapy and the evolving clinical algorithms surrounding those agents predictably dominated the list of topics reviewed in the journal. The incremental progress in progression free survival has been the major story and the key thread in the narrative on treating the disease.
However, the topics highlighted inthis issue will be of sharp interest as well to all physicians engaged in the treatment of renal cell carcinoma. As treatment strategies have evolved dramatically, our approach in the surgical theater to the disease is also exciting and the two articles by Michael L. Blute, MD and Eric Jonasch, MD, suggest how far we have come in addressing controversies in this setting.
To continue reading the Guest Editor's Memo, and the rest of the issue, click here.
Slower internet connections will increase the time it takes to open, turn and enlarge the pages. When you see an active hyperlink within the general text, an article (not the references), or in an ad unit, you can click that link to send an e-mail or be taken to that web page.
